Analysts Set Nano-X Imaging Ltd. (NASDAQ:NNOX) Price Target at $4.00

Shares of Nano-X Imaging Ltd. (NASDAQ:NNOX) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, one has given a buy recommendation and two have assigned a strong buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $4.00.

A number of brokerages have issued reports on NNOX. D. Boral Capital reaffirmed a “buy” rating and issued a $5.00 price objective on shares of Nano-X Imaging in a research report on Monday, April 20th. Zacks Research raised shares of Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. Alliance Global Partners downgraded Nano-X Imaging from a “buy” rating to a “neutral” rating and cut their target price for the stock from $5.00 to $3.00 in a research note on Tuesday, July 7th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Nano-X Imaging in a report on Wednesday, July 8th.

Nano-X Imaging Trading Up 1.0%

Shares of NASDAQ:NNOX opened at $1.06 on Wednesday. The stock has a market cap of $73.77 million, a PE ratio of -0.67 and a beta of 1.24. The stock’s fifty day simple moving average is $1.61 and its two-hundred day simple moving average is $2.21. Nano-X Imaging has a 1-year low of $0.73 and a 1-year high of $5.69.

Nano-X Imaging (NASDAQ:NNOX) last announced its earnings results on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. The firm had revenue of $4.31 million during the quarter. On average, sell-side analysts forecast that Nano-X Imaging will post -0.6 earnings per share for the current fiscal year.

Nano-X Imaging News Roundup

Here are the key news stories impacting Nano-X Imaging this week:

• Negative Sentiment: Multiple law firms announced or promoted class-action lawsuits against Nano-X Imaging and urged investors who bought shares during the class period to seek lead-plaintiff status before the August 11, 2026 deadline, increasing legal overhang and uncertainty. Article Title
• Negative Sentiment: The lawsuits and investor alerts specifically reference alleged investor harm tied to Nano-X’s financial reporting and restructuring disclosures, which can weigh on sentiment and raise concerns about execution and future cash needs. Article Title
• Neutral Sentiment: Nano-X Imaging was also noted as set to release earnings soon, which could provide a fresh catalyst if results or guidance show improvement, but no new operating update was included in these notices. Article Title

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Interchange Capital Partners LLC bought a new position in Nano-X Imaging in the 4th quarter valued at $28,000. Aristides Capital LLC bought a new stake in shares of Nano-X Imaging during the 4th quarter worth $30,000. CIBC Bancorp USA Inc. purchased a new position in shares of Nano-X Imaging in the 3rd quarter worth about $40,000. Independent Financial Group LLC purchased a new position in shares of Nano-X Imaging in the 1st quarter worth about $26,000. Finally, Kestra Advisory Services LLC bought a new position in Nano-X Imaging during the first quarter valued at about $26,000. Hedge funds and other institutional investors own 21.49% of the company’s stock.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.